Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Cancer Research|January 15, 1988
Reevaluation of the maximum tolerated dose of continuous venous infusion of 5-fluorouracil with pharmacokineticsD V Spicer, B Ardalan, J R Daniels, et al.
Journal of Chemotherapy (Florence, Italy)|March 18, 2008
Differential expression of Glut 1 mRNA and protein levels correlates with increased sensitivity to the glyco-conjugated nitric oxide donor (2-glu-SNAP) in different tumor cell typesP R Subbarayan, P G Wang, T J Lampidis, et al.
Cancer|September 15, 1992
Phase II trial of 4'-0-tetrahydropyranyladriamycin (pirarubicin) in head and neck carcinomaK S Sridhar, A M Hussein, P Benedetto, et al.
The Cancer Journal From Scientific American|April 3, 1999
Increased thymidylate synthase gene expression in liver metastases from colorectal carcinoma: implications for chemotherapeutic options and survivalO F Bathe, D Franceschi, A S Livingstone, et al.
Cancer Treatment Reports|August 1, 1980
Peripheral leukocytes as indicators of the enzymatic effects of N-(phosphonacetyl)-L-aspartic acid (PALA) on human L-aspartate transcarbamoylase (ATCase) activityT W Kensler, C Erlichman, H N Jayaram, et al.
Investigational New Drugs|January 1, 1996
Phase II trial of low-dose N-(phosphonacetyl)-disodium L-aspartic acid and high-dose 24-hour infusional 5-fluorouracil in advanced gastric adenocarcinoma. A Southwest Oncology Group studyR L Martino, T R Fleming, L M Morrell, et al.
Cancer|October 1, 1994
Phase I trial of low dose N-phosphonacetyl-L-aspartic acid and high dose 5-fluorouracil administered concomitantly with radiation therapy for unresectable localized adenocarcinoma of the pancreasB Ardalan, A Ucar, R Reddy, et al.
Cancer Research|May 1, 1980
Mechanisms of sensitivity and resistance of murine tumors to 5-fluorouracilB Ardalan, D A Cooney, H N Jayaram, et al.
Cancer Research|September 1, 1985
Pharmacokinetic and biochemical studies on acivicin in phase I clinical trialsJ P McGovren, E A Pratt, R J Belt, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1992
Phase I study of high dose 5-fluorouracil and high dose Leucovorin with low dose phosphonacetyl-L-aspartic acid in patients with advanced malignanciesB Ardalan, K Stridhar, R Reddy, et al.
Pageof 5